CATEGORY : Diagnostics Market

Life Science Market Reports

Our life science market intelligence products have been recognized by market insiders and outsiders alike for their accuracy, in-depth analysis, and unique insights.

Market Reports

Emmes Data Insights: Supply-Chain Constraints Hinder Diagnostic Testing Capabilities

  Months into the COVID-19 pandemic, U.S. testing capacity continues to lag behind its goals. The Harvard Global Institute estimated that the U.S should have at least 900,000 SARS-CoV-2 tests

View Details

Emmes Data Insights: Hospital Labs’ Readiness for the Coronavirus Testing Onslaught

  SARS-CoV-2 media attention has largely focused on diagnostic reference labs as they have scaled up testing capacity. However, hospital labs, which drive the vast majority of seasonal respiratory virus

View Details

2020 Vision: 3 Recent Advancements in Computer Vision for Health

  The advent of computer vision – deep learning models trained on image data to classify, annotate, or otherwise characterize new images – offers a powerful toolkit for analyzing medical

View Details

Collaborative, Decentralized Research Drives Liquid Biopsy Advances – AGBT 2020

  For AGBT 2020, we analyzed collaboration networks within liquid biopsy publications to understand the landscape. We analyzed ~2,600 liquid biopsy publications 1, indexing ~1,300 affiliations and ~15,000 authors in 60

View Details

Supplying the COVID Demand — How Dx Behemoths and Tele-Diagnostics Entrants Aim to Close the Gap

  As more COVID-19 diagnostics win FDA emergency use authorization, weekly commercial production capacity is expected to hit 6.5M+ tests; telehealth providers attempt to jump into the fray, but are

View Details

A 2020 Look at 3 Trends in Immuno-Oncology Biomarkers

We recently added >300 new trials to our I/O biomarker clinical trial tracker, The I/O BioMAP, bringing our running total to ~2,700 studies, and providing new data that sheds light

View Details

How KKR Made a ~3x Return in 4 Years by Investing in Research Tools

  KKR made headlines late last year with the exit of their investment in LGC Group, a UK-based biochemical standards and reagents provider. Sources say KKR acquired LGC in December

View Details

Going Viral: What the COVID-19 Outbreak Teaches Us About the Evolution of the Biotech Industry

  The novel coronavirus (COVID-19) outbreak has been a huge topic of concern across the globe as infection and death tolls continue to grow daily. However, it’s inarguable that the

View Details

3 Takeaways for Digital Health from #CES2020

Consumer health techs hone clinical value propositions Criticism of the digital health space has largely centered on the lack of clinical utility and validity as a result of technologies built

View Details

How can we help?

Avoid blind spots in your market. Get the insights you need to accelerate innovation.

Contact Us